+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens



Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens



Oncology Research 6(6): 269-279



The schedule-dependent cytotoxic effects of topotecan were evaluated in tissue culture experiments with Chinese hamster V79 cells. One hour exposure to topotecan resulted in a typical phase-specific cell killing curve in which increasing concentrations kill progressively more cells and then reach a plateau when all susceptible cells are killed. In contrast, exposure for 24 h results in a steep concentration-response curve with no plateau. Other S-phase agents such as hydroxyurea or aphidicolin antagonized cytotoxicity when administered by simultaneous exposure with topotecan. Combinations of melphalan, BCNU (1,3 bis(2-chloroethyl)-1-nitrosourea), or cisplatinum with topotecan were most effective when cells were exposed to the alkylating agent or platinating agent during the first hour of a 24-h topotecan exposure. Combinations of topotecan with etoposide or adriamycin produce more cytotoxicity when topotecan is administered by prolonged exposure; however, there is no significant difference depending on whether the topoisomerase II inhibitor is added at the beginning or end of the topotecan exposure. These studies show the importance of appropriate dose scheduling to obtain optimal interaction of chemotherapeutic agents given in combination with topotecan.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009380295

Download citation: RISBibTeXText

PMID: 7865902


Related references

Schedule dependent cytotoxicity of ara-C and mitoxantrone combination chemotherapy correlates with DNA single strand breaks. Proceedings of the American Association for Cancer Research Annual Meeting 37: 294, 1996

Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes. Journal of Controlled Release 146(3): 326-333, 2010

Topoisomerase I protein levels involved in schedule-dependent cytotoxicity of topotecan or SN-38 and platinum and drugs in vitro. Proceedings of the American Association for Cancer Research Annual Meeting 40: 108-109, 1999

Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome. Cancer 106(5): 1099-1109, 2006

Platinum adduct removal in relation to schedule-dependent cytotoxicity of topotecan or SN-38 and platinum and compounds in vitro. Proceedings of the American Association for Cancer Research Annual Meeting 39: 526, 1998

Schedule-dependent cytotoxicity of 5-fluorouracil and cyclophosphamide in experimental cancer chemotherapy. European Journal of Cancer 16(5): 699-705, 1965

Schedule dependent synergistic cytotoxicity on l 5187y cells from methotrexate m ara c c and dipyridamole d m dc d combination. Proceedings of the American Association for Cancer Research Annual Meeting 31: 387, 1990

A new combination chemotherapy using topotecan, fludarabine, Ara-C and G-CSF for aggressive myelodysplastic syndromes and acute myelogenous leukemia in the elderly Dose finding for topotecan study. Blood 94(10 Suppl. 1 Part 1): 307a, 1999

Combined treatment of bladder cancer cell lines with lapatinib and varying chemotherapy regimens--evidence of schedule-dependent synergy. Urology 69(2): 390-394, 2007

The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity. International Journal of Oncology 15(2): 209-216, 1999

Combination chemotherapy with CPT-11 and BCNU displays schedule dependent activity against malignant glioma. Proceedings of the American Association for Cancer Research Annual Meeting 40: 109, 1999

Effects of 2 body weight reduction regimens on schedule dependent and schedule induced behavior. Physiology and Behavior 21(4): 639-646, 1978

Effects of two body weight reduction regimens on schedule dependent and schedule induced behavior. Physiology and Behavior 21(4): 639-645, 1978

Influence of hydration schedule on pharmacokinetic profiles in the combination cisplatin followed by topotecan. Proceedings of the American Association for Cancer Research Annual Meeting 43: 429, 2002

Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells. Cancer Treatment Reports 65(Suppl. 4): 115-121, 1981